[Lys3]-Bombesin - 5 mg
- Cat.Number : AS-22838
- Manufacturer Ref. :
-
Availability :
In stock
PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
CAS registry number |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
You may also be interested in the following product(s)



References
microPET and Autoradiographic Imaging of GRP Receptor Expression with 64Cu-DOTA-[Lys3]Bombesin in Human Prostate Adenocarcinoma Xenografts
J Nucl Med . 2004 Aug 01 ; 45(8) 1390 | DOI : PMID: 15299066
- X. Chen
- et al
Design, Synthesis, and Initial Evaluation of High-Affinity Technetium Bombesin Analogues
Bioconjug Chem . 1998 Feb 18 ; 9(2) 218 | DOI : https://doi.org/10.1021/bc9701959
- K. Baidoo
- et al